Session » Systemic Sclerosis, Fibrosing Syndromes, and Raynaud's - Clinical Aspects and Therapeutics II
-
Abstract Number: 3134
Safety and Tolerability of Pirfenidone in Patients with Systemic Sclerosis Interstitial Lung Disease
-
Abstract Number: 3135
Incidences and Predictors of Organ Manifestations in the Early Course of Systemic Sclerosis: A Longitudinal Study
-
Abstract Number: 3136
Impact of Prokinetic Agents on Systemic Sclerosis-Associated Gastrointestinal Disease: A Systematic Review
-
Abstract Number: 3137
Scleroderma Hand Contracture Study
-
Abstract Number: 3138
Prognostic Role of Ventricular Ectopic Beats in Systemic Sclerosis